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INTRODUCTION
Perinatal hypoxic-ischemic brain damage is a major cause of acute mortality and chronic neurologic morbidity in infants and children. Perinatal hypoxic-ischemia is accompanied by neurodegeneration, including necrotic and apoptotic neuronal death [1, 2] . Neuronal apoptosis is closely associated with brain damage induced by ischemia/reperfusion injury [3] [4] [5] .
Apoptosis plays a crucial role in normal development and tissue homeostasis. Nevertheless, inappropriate or excessive apoptosis is implicated in several neurological disorders [3, 6, 7] . end labeling (TUNEL) assay can detect DNA fragmentation, which is a characteristic of apoptotic cell death. An increase in the number of TUNEL-positive cells is reflective of apoptotic cell death [3, 6, 8] .
Another important characteristic of apoptosis is activation of caspases. Caspase-3 is one of the most widely studied caspases, and plays a key-role in apoptosis. In ischemic animal models, caspase-3 activation is implicated in neuronal apoptosis [3, 5, 9] . In addition, the Bcl-2 family of proteins also plays a pivotal role in the regulation of apoptosis. Bcl-2 proteins are classified into 2 groups: the antiapoptotic protein Bcl-2 and the pro-apoptotic protein Bax [10] . The balance between pro-apoptotic and antiapoptotic Bcl-2 family members determines the mitochondrial response to apoptotic stimuli [11] . Enhancement of neuronal apoptosis by increases in Bax accompanied by decreases in Bcl-2 contributes to central nervous system dysfunction [6, 12] .
Pentoxifylline is a methylxanthine derivative and type-4 phosphodiesterase (PDE-4) inhibitor. It is widely used for the management of peripheral vascular diseases, particularly for intermittent claudication and cerebrovascular disease caused by impairment of microcirculation [13, 14] . PDE-4 selective inhibitors have potential for therapeutic use [15] . They are highly specific for the hydrolysis of 3ʹ-5ʹ-cyclic adenosine monophosphate (cAMP), and are thus a key modulator of intracellular cAMP signaling pathways. cAMP plays critical roles in modulating brain functions, including neural circuit excitability, memory, and apoptosis [16, 17] .
The protective effects of pentoxifylline on ischemic injuries in the lung, intestine, liver, and kidney have been demonstrated [18] [19] [20] . Many interventions have been investigated for the treatment of perinatal hypoxic-ischemic brain damage. However, no practical treatment method has been established for perinatal hypoxic-ischemic injury.
We investigated the effects of pentoxifylline on short-term memory and neuronal apoptosis in the hippocampus following hypoxic-ischemia in neonatal rats. Methodologies used to evaluate these effects included a step-down avoidance task, cAMP assay, TUNEL assay to detect DNA fragmentation, immunohistochemistry for caspase-3, and western-blot for Bcl-2 and Bax detection.
MATERIALS AND METHODS

Experimental Animals
Neonatal Sprague-Dawley rats (7 days old, 10-15 g in weight)
were procured from a commercial breeder (Orient Co., Seoul, Korea). They were randomly divided into 4 groups (n = 10 in each group): sham-operation group, perinatal hypoxic-ischemia-induced group, perinatal hypoxic-ischemia-induced and 50-mg/kg pentoxifylline-treated group, and perinatal hypoxicischemia-induced and 100-mg/kg pentoxifylline-treated group.
Induction of Perinatal Hypoxic-Ischemia in Neonatal Rats
Perinatal hypoxic-ischemia was induced as previous method [4] . Neonatal rats were anesthetized with isoflurane (2% isoflurane in 30% O2 and 70% N2; Vibac Laboratories, Carros, France). Following a neck incision, the right common carotid artery was permanently ligated with a 5-0 surgical silk suture. Subsequently, neonatal rats were placed in a chamber containing humidified 8% O2 and 92% N2 for 90 minutes. For the neonatal rats in the sham-operation group, surgical incision was performed without ligation and without exposure to hypoxic conditions.
Drug Treatment
Neonatal rats in the pentoxifylline-treated groups received pentoxifylline (Sigma-Aldrich Chemical Co., St. Louis, MO, USA) intraperitoneally once a day for 7 consecutive days, starting one day after induction of perinatal hypoxic-ischemia. Neonatal rats in the sham-operation and hypoxic-ischemia-induced groups received an equal amount of saline intraperitoneally for the same duration.
Step-Down Avoidance Task
Latency in the step-down avoidance task was determined as described previously [5, 21] . Rat pups (5 weeks old, 120-130 g in weight) were trained in a step-down avoidance task 28 days after induction of hypoxic-ischemia. Rat pups were placed on a 7×25-cm platform 2.5 cm high. The platform faced a 42×25-cm grid of parallel 0.1-cm caliber stainless steel bars spaced 1 cm apart. During the training session, the animals received 0.5-mA scrambled foot shocks for 2 seconds immediately upon stepping down. Two hours after training, the latency (s) was determined. The interval between the rat stepping down and placing all 4 paws on the grid was defined as the latency time. Latency over 180 seconds was counted as 180 seconds.
Tissue Preparation
Rat pups were sacrificed immediately after determining the latency in the step-down avoidance task. The animals were anesthetized using Zoletil 50 (10 mg/kg, intraperitoneally; Virbac Laboratories), transcardially perfused with 50mM phosphatebuffered saline, and then fixed with a freshly prepared solution of 4% paraformaldehyde in 100mM phosphate buffer (pH 7.4). Brains were then dissected, postfixed in the same fixative overnight, and transferred to 30% sucrose for cryoprotection. A freezing microtome (Leica, Nussloch, Germany) was used to generate 40-μm-thick coronal sections.
Assay for Cyclic AMP
The cAMP assay was performed using a commercially available cAMP competitive enzyme immunoassay kit (Sapphire Bioscience Pty. Ltd., Redfern, Australia) according to the manufacturer's instruction [5] .
TUNEL Staining
TUNEL staining was performed using an In Situ Cell Death Detection Kit (Roche, Mannheim, Germany) according to the manufacturer's protocol [5, 8] . The sections were postfixed in ethanol-acetic acid (2:1) and rinsed. The sections were then incubated with proteinase K (100 μg/mL), rinsed, and incubated in 3% H2O2, permeabilized with 0.5% Triton X-100, rinsed again, and incubated in the TUNEL reaction mixture. The sections were then rinsed and visualized using Converter-POD with 0.03% 3, 3ʹ-diaminobenzidine (DAB). Mayer's hematoxylin (DAKO, Glostrup, Denmark) was used as a counterstain, and the sections were mounted onto gelatin-coated slides.
Caspase-3 Immunohistochemistry
Caspase-3 immunohistochemistry was performed as described previously [5, 22] . The sections were incubated overnight with mouse anti-caspase-3 antibody (1:500; Santa Cruz Biotechnology, Santa Cruz, CA, USA), followed by incubation with biotinylated mouse secondary antibody (1:200; Vector Laboratories, Burlingame, CA, USA) for another one hour. The secondary antibody was amplified with the Vector Elite ABC kit (1:100; Vector Laboratories). Antibody-biotin-avidin-peroxidase complexes were visualized using 0.03% DAB, and sections were mounted onto gelatin-coated slides.
Western Blot Analysis
Western blot analysis was performed as described previously [3, 6] . Hippocampal tissues were homogenized with lysis buffer. Protein content was measured using a Bio-Rad colorimetric protein assay kit (Bio-Rad, Hercules, CA, USA). The protein mixture containing 40 μg total protein was separated on sodium dodecyl sulfate-polyacrylamide gels and transferred onto a nitrocellulose membrane. Mouse actin antibody (1:2,000; Santa Cruz Biotechnology), mouse Bax antibody (1:1,000; Santa Cruz Biotechnology) and mouse Bcl-2 antibody (1:1,000; Santa Cruz Biotechnology) were used as primary antibodies. Horseradish peroxidase-conjugated antimouse antibodies for Bax and Bcl-2 (1:2,000; Amersham Pharmacia Biothech GmbH, Freiburg, Germany) were used as secondary antibodies. Bands were detected using an enhanced chemiluminescence detection kit (Santa Cruz Biotechnology).
Data Analysis
The number of TUNEL-positive and caspase-3-positive cells was expressed as number of cells per square millimeter in the CA1 region. To compare relative expression of proteins, we evaluated the detected bands densitometrically using Molecular Analyst ver. 1.4.1 (Bio-Rad). Statistical analysis was performed using one-way analysis of variance followed by Duncan post hoc test, and the results are expressed as mean ± standard error of the mean. Significance was set at P < 0.05.
RESULTS
Effect of Pentoxifylline on Short-term Memory
Short-term memory was disrupted by perinatal hypoxic-ischemic injury (P < 0.05), and pentoxifylline alleviated this memory impairment (P < 0.05) (Fig. 1) .
Effect of Pentoxifylline on cAMP Levels in the Hippocampus
Hippocampal cAMP levels were decreased by perinatal hypoxic-ischemic injury (P < 0.05), and pentoxifylline increased the cAMP levels (P < 0.05) (Fig. 2) .
Effect of Pentoxifylline on DNA Fragmentation in the Hippocampal CA1 Region
DNA fragmentation in the CA1 region was increased by perinatal hypoxic-ischemic injury (P<0.05), and pentoxifylline suppressed this increase in DNA fragmentation (P<0.05) (Fig. 3) .
Effect of Pentoxifylline on Caspase-3 Expression in the Hippocampal CA1 Region
Caspase-3 expression in the CA1 region was enhanced by perinatal hypoxic-ischemic injury (P<0.05), and pentoxifylline suppressed this increase in caspase-3 expression (P<0.05) (Fig. 4) . 
Effect of Pentoxifylline on Bax and Bcl-2 Expressions in the Hippocampus
Perinatal hypoxic-ischemic injury increased Bax expression (P < 0.05) and decreased Bcl-2 expression (P < 0.05). Pentoxifylline suppressed Bax expression (P < 0.05) and enhanced Bcl-2 expression (P < 0.05). As a result, the ratio of Bax to Bcl-2 was Effect of pentoxifylline on 3ʹ-5ʹ-cyclic adenosine monophosphate (cAMP) levels in the hippocampus. A, Sham-operation group; B, perinatal hypoxic-ischemia-induced group; C, perinatal hypoxic-ischemia-induced and 50-mg/kg pentoxifylline-treated group; D, perinatal hypoxic-ischemia-induced and 100-mg/kg pentoxifylline-treated group. *P < 0.05 compared to the sham-operation group. # P < 0.05 compared to the perinatal hypoxic-ischemia-induced group. § P < 0.05 compared to the perinatal hypoxic-ischemia-induced and 50-mg/kg pentoxifylline-treated group. increased by perinatal hypoxic-ischemic injury (P < 0.05), and pentoxifylline suppressed this increase in the ratio of Bax to Bcl-2 (P < 0.05) (Fig. 5) .
DISCUSSION
Perinatal hypoxic-ischemic brain damage induces learning and memory deficits in rats [23, 24] . Decreasing latency in the stepdown avoidance task represents impairment of short-term memory [22, 25] . In this study, the latency in the step-down avoidance task was decreased by the induction of perinatal hypoxic-ischemia. These results reveal that perinatal hypoxicischemia disrupted short-term memory in the rat pups. Enhanced apoptosis is implicated in several types of injuries [5, 26, 27] . In gerbils with ischemic injury, the number of TU-NEL-positive and caspase-3-positive cells in the hippocampal CA1 region increased [25, 28] . In this study, the number of TU-NEL-positive and caspase-3-positive cells in the hippocampal CA1 region increased following perinatal hypoxic-ischemia. These results indicate that perinatal hypoxic-ischemia induced apoptotic neuronal cell death in the hippocampal CA1 region.
The Bcl-2 family of proteins, including Bcl-2 and Bcl-XL, play an important role in the regulation of apoptosis in the nervous system [29] . Bcl-2 inhibits apoptosis; however, Bcl-2 and Bcl-XL form heterodimers with the main pro-apoptotic member Bax, and inhibit its protective function [10] . Hence, the balance between Bax and Bcl-2 proteins is the crucial factor that regulates apoptosis [26, 27] . Neonatal hypoxic-ischemic injury in the brain increased Bax levels with a decrease in Bcl-2 levels beginning 6 hours after the insult [30] . In this study, perinatal hypoxic-ischemic injury increased Bax expression and decreased Bcl-2 levels. Thus, the Bax to Bcl-2 ratio increased, indicating that perinatal hypoxic-ischemic injury initiated apoptotic cell death in the hippocampus.
Eun et al. [31] showed that pentoxifylline reduced infarction size in the cerebral cortex following neonatal hypoxic-ischemic brain injury. Kalay et al. [32] reported that pentoxifylline suppressed caspase-3 activity, and inhibited the expression of interleukin-1β and tumor necrosis factor-α mRNA in the left half of the brain after hypoxic-ischemic encephalopathy in neonatal rats.
Decrease in the number of TUNEL-positive and caspase-3-positive cells in ischemic gerbils represents anti-apoptotic effects [25, 28] . Decrease in the ratio of Bax to Bcl-2 also suggests inhibition of apoptosis in ischemic gerbils [25, 28] . In this study, pentoxifylline suppressed the perinatal hypoxic-ischemia-induced increase in DNA fragmentation and caspase-3 expression in the hippocampal CA1 region. Pentoxifylline also suppressed Bax expression and enhanced Bcl-2 expression, resulting in a decreased Bax to Bcl-2 ratio. These results show that pentoxifylline inhibited perinatal hypoxic-ischemia-induced apoptosis in the hippocampus. During learning and memory, cAMP levels are elevated via a PDE-4-dependent process [15] . Inhibition of cAMP-dependent protein kinase A activation impairs conditioned fear memory [17] . In the present results, cAMP levels show a positive correlation with improvement of short-term memory and a negative correlation with apoptosis.
Our study demonstrates that pentoxifylline suppressed apoptosis in the hippocampus and improved short-term memory after perinatal hypoxic-ischemia. This alleviating effect on short-term memory impairment can be attributed to the inhibition of apoptosis due to increase in cAMP production by pentoxifylline. 
